GRASSILLI, EMANUELA
 Distribuzione geografica
Continente #
NA - Nord America 4.659
EU - Europa 2.852
AS - Asia 2.267
SA - Sud America 327
AF - Africa 60
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 3
Totale 10.180
Nazione #
US - Stati Uniti d'America 4.553
SG - Singapore 835
IT - Italia 780
DE - Germania 673
CN - Cina 488
RU - Federazione Russa 284
VN - Vietnam 267
HK - Hong Kong 254
BR - Brasile 248
SE - Svezia 247
GB - Regno Unito 189
IE - Irlanda 163
UA - Ucraina 130
FR - Francia 90
IN - India 87
CA - Canada 76
ID - Indonesia 66
DK - Danimarca 60
FI - Finlandia 59
AT - Austria 49
BD - Bangladesh 36
KR - Corea 35
TR - Turchia 33
IQ - Iraq 27
AR - Argentina 25
PK - Pakistan 25
JP - Giappone 22
NL - Olanda 21
PL - Polonia 18
SA - Arabia Saudita 18
ES - Italia 17
BE - Belgio 16
MX - Messico 16
CO - Colombia 15
VE - Venezuela 13
CH - Svizzera 12
MA - Marocco 12
ZA - Sudafrica 12
EU - Europa 11
PH - Filippine 11
UZ - Uzbekistan 11
KE - Kenya 10
LT - Lituania 10
CL - Cile 9
PY - Paraguay 7
RS - Serbia 7
CZ - Repubblica Ceca 6
EC - Ecuador 6
EG - Egitto 6
IR - Iran 5
LB - Libano 5
OM - Oman 5
TN - Tunisia 5
AL - Albania 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
HR - Croazia 4
IL - Israele 4
JO - Giordania 4
MU - Mauritius 4
MY - Malesia 4
NP - Nepal 4
ET - Etiopia 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
PE - Perù 3
PS - Palestinian Territory 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BG - Bulgaria 2
BY - Bielorussia 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LY - Libia 2
PT - Portogallo 2
SN - Senegal 2
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
LI - Liechtenstein 1
NZ - Nuova Zelanda 1
PA - Panama 1
RO - Romania 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.180
Città #
Ann Arbor 1.313
Frankfurt am Main 535
Singapore 524
Ashburn 421
Milan 378
San Jose 322
Wilmington 244
Hong Kong 241
Chandler 159
Dublin 159
Fairfield 134
Dearborn 114
New York 114
Jacksonville 98
Houston 96
Woodbridge 91
Los Angeles 86
Ho Chi Minh City 81
The Dalles 77
Beijing 75
Santa Clara 72
Chicago 66
Council Bluffs 65
Seattle 62
Hanoi 59
Jakarta 57
Princeton 57
Dallas 56
Cambridge 46
Shanghai 44
Mcallen 43
Vienna 41
Hefei 40
Lauterbourg 32
Nanjing 30
Kent 29
Seoul 29
São Paulo 29
Guangzhou 27
Helsinki 24
London 24
Buffalo 22
Munich 22
Boardman 19
Altamura 18
Tokyo 18
Lachine 17
Lawrence 16
Ottawa 16
Warsaw 15
Brooklyn 14
Lissone 14
Orem 14
Shenyang 14
Toronto 14
Brussels 13
Chennai 13
Moscow 13
Pune 13
Segrate 13
Zhengzhou 13
Denver 12
Montreal 12
Monza 12
Phoenix 12
San Diego 12
Amsterdam 11
Atlanta 11
Da Nang 11
Kunming 11
Manchester 11
Nanchang 11
Tashkent 11
Dhaka 10
Lappeenranta 10
Medellín 10
Sacramento 10
San Francisco 10
Turin 10
Auburn Hills 9
Changsha 9
Dong Ket 9
Edmonton 9
Haiphong 9
Nuremberg 9
Tianjin 9
Baghdad 8
Hebei 8
Jinan 8
Boston 7
Karachi 7
Mexico City 7
Nairobi 7
Poplar 7
Rio de Janeiro 7
Rome 7
Zurich 7
Biên Hòa 6
Caracas 6
Florence 6
Totale 6.863
Nome #
A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation 639
Inhibition of GSK3B Bypass Drug Resistance of p53-null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy 607
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers 575
Combinations of a btk inhibitor and fluorouracil for treating cancers 569
Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype 549
Pharmaceutical kit for use in the treatment of colon and colorectal cancer 530
GSK3A Is Redundant with GSK3B in Modulating Drug Resistance and Chemotherapy-Induced Necroptosis 513
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma 477
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study. 445
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 435
Unexpected frequency of genomic alterations in histologically normal colonic tissue from colon cancer patients 368
Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer 358
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer 300
The antiangiogenic effect of the metronomic combination of 5-Fluorouracil plus vinorelbine is mediated by FAK/AKT pathway downregulation and apoptosis activation 282
The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells 280
p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors 278
Methods for determining the sensitivity or resistance of cancer cells to at least one anticancer drug and/or therapeutically active molecule 265
Emerging actionable targets to treat therapy-resistant colorectal cancers 245
Identifying novel actionable targets in colon cancer 243
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation 234
Isoform of bruton's tyrosine kinase (BTK) protein 214
BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression 211
NEW ISOFORM OF BRUTON’S TYROSINE KINASE (BTK) PROTEIN 207
Modulator compounds of the drug resistance in epithelial tumour cells 204
Isoform of Bruton's tyrosine kinase (BTK) protein 202
Isoform of bruton's tyrosine kinase (BTK) protein 199
Btk inhibitors for use in treating chemotherapeutic drug-resistant epithelial tumours 196
Modulator compounds of the drug resistance in epithelial tumour cells 185
Modulator compounds of the drug resistance in epithelial tumour cells 174
"Ironing out" fasting-induced persister cancer cells to render chemotherapy effective: is this the solution? 170
BTK, the new kid on the (oncology) block? 162
Editorial: Targeting Bruton Tyrosine Kinase 158
Modulator compound of the drug resistance in epithelial tumor cells 146
Targeting p65BTK for treating solid cancers 131
Totale 10.751
Categoria #
all - tutte 31.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.466


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021360 0 0 0 0 0 0 0 0 0 145 98 117
2021/2022639 90 83 96 57 24 40 25 16 18 12 79 99
2022/20231.112 126 288 145 115 85 142 34 58 52 13 24 30
2023/2024650 32 22 27 61 57 153 110 37 15 43 7 86
2024/20251.414 82 131 101 63 117 75 85 46 142 238 120 214
2025/20263.304 423 192 277 355 485 212 651 132 280 297 0 0
Totale 10.751